MUSTANG BIO, INC. Derivative Liability, Current
MUSTANG BIO, INC. (MBIO) had Derivative Liability, Current of $632.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2016-11-14
- 2016-09-30: Derivative Liability, Current $632.00K.
- 2015-12-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2016-09-30 | $632.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |